A comprehensive view of regeneron pharmaceuticals inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
Recent Articles
sample of recent headlines, press releases and get more..
US Patent Issued to Regeneron Pharmaceuticals on Jan. 24 for "Fucosylation-deficient cells" (New York Inventors)
Published:
January 25, 2023
by U.S. Fed News
|
US Patent Issued to REGENERON PHARMACEUTICALS on Jan. 24 for "Use of a VEGF antagonist to treat angiogenic eye disorders" (New York Inventor)
Published:
January 25, 2023
by U.S. Fed News
|
INTERNATIONAL PATENT: REGENERON PHARMACEUTICALS, INC. FILES APPLICATION FOR "PROTEIN N-TERMINAL DE NOVO SEQUENCING BY POSITION-SELECTIVE DIMETHYLATION"
Published:
January 25, 2023
by U.S. Fed News
|
INTERNATIONAL PATENT: REGENERON PHARMACEUTICALS, INC. FILES APPLICATION FOR "MASS SPECTROMETRY-BASED STRATEGY FOR DETERMINING PRODUCT-RELATED VARIANTS OF A BIOLOGIC"
Published:
January 25, 2023
by U.S. Fed News
|
INTERNATIONAL PATENT: REGENERON PHARMACEUTICALS, INC. FILES APPLICATION FOR "ANTI-SARS-COV-2-SPIKE GLYCOPROTEIN ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS"
Published:
January 25, 2023
by U.S. Fed News
|
Ask us about our Health Care Sector market view
Trending Chart
Interactive chart with headline count